Racemic gamma vinyl-GABA (R,S-GVG) blocks methamphetamine-triggered reinstatement of conditioned Place preference

Synapse

Volumn 63, Issue 2, 2009, Pages 87-94

  Demarco, A M Y ^a   Dalal, Reema M ^b   Jessica, P A I ^b   Aquilina, Stefanie D ^c   Mullapudi, U M A ^d   Hammel, Crystie ^a   Kothari, Shiva K ^e   Kahanda, Milan ^f   Liebling, Courtney N B ^a   Patel, Vinal ^a   Schiffer, Wynne K ^a   Brodie, Jonathan D ^b   Dewey, Stephen L ^a,b  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c Department of Obstetrics Gynecology   (United States)

^d DARTMOUTH COLLEGE   (United States)

^e DUKE UNIVERSITY   (United States)

^f RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

GABA; Conditioned place preference; Methamphetamine; Reinstatement; Relapse; Vigabatrin

Indexed keywords

METHAMPHETAMINE; SODIUM CHLORIDE; VIGABATRIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG EXPOSURE; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; RELAPSE;

AMPHETAMINE-RELATED DISORDERS; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, CLASSICAL; EXTINCTION, PSYCHOLOGICAL; GABA AGENTS; ISOMERISM; MALE; METHAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECURRENCE; VIGABATRIN;

EID: 59949094486     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20582     Document Type: Article

References (73)

1. Anggadiredja K, Sakimura K, Hiranita T, Yamamoto T. 2004. Naltrexone attenuates cue- but not drug-induced methamphetamine seeking; a possible mechanism for the dissociation of primary and secondary reward. Brain Res 1021:272-276.
2. B receptor in γ vinyl-GABA's inhibition of cocaineinduced increases in nucleus accumbens dopamine. Synapse 31:151-153.
3. Bardo MT, Bevins RA. 2000. Conditioned place preference: What does it add to our preclinical understanding of drug reward? Psychopharmacology 153:31-43.
4. Boctor SY, Martinez JL Jr, Koek W, France CP. 2007. The cannabinoid CB1 receptor antagonist AM251 does not modify methamphetamine reinstatement of responding. Eur J Pharmacol 571:39-43.
5. Brodie JD, Figueroa E, Dewey SL. 2003. Treating cocaine addiction: From preclinical to clinical trial experience with g-vinyl GABA. Synapse 50:261-265.
6. Brodie JD, Figueroa E, Laska EM, Dewey SL. 2005. Safety and efficacy of γ-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction. Synapse 55:122-125.
7. Cameron DL, Williams JT. 1994. Cocaine inhibits GABA release in
8. the VTA through endogenous 5-HT. J Neurosci 14:6763-6767.
9. Centonze D, Picconi B, Baunez C, Borrelli E, Pisani A, Bernardi G, Calabresi P. 2002. Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors. Neuropsychopharmacology 26:164-175.
10. Cruz FC, Marin MT, Planeta CS. 2008. The reinstatement of amphetamine-induced place preference is long-lasting and related to decreased expression of AMPA receptors in the nucleus accumbens. Neuroscience 151:313-319.
11. Cunningham CL, Ferree NK, Howard MA. 2003. Apparatus bias and place conditioning with ethanol in mice. Psychopharmacology 170:409-422.
12. Davidson C, Gopalan R, Ahn C, Chen Q, Mannelli P, Patkar AA, Weese GD, Lee TH, Ellinwood EH. 2007. Reduction in methamphetamine induced sensitization and reinstatement after combined pergolide plus ondansetron treatment during withdrawal. Eur J Pharmacol 565:113-118.
13. Daza-Losada M, Ribeiro Do Couto B, Manzanedo C, Aguilar MA, Rodríguez-Arias M, Miñarro J. 2008. Rewarding effects and reinstatement of MDMA-induced CPP in adolescent mice. Neuropsy-chopharmacology 32:1750-1759.
14. Daza-Losada M, Rodríguez-Arias M, Aguilar MA, Miñarro J. 2008. Effect of adolescent exposure to MDMA and cocaine on acquisition and reinstatement of morphine-induced CPP. Prog Neuropsychopharmacol Biol Psychiatry 32:701-709.
15. de Wit H, Stewart J. 1981. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology 75:134-143.
16. Dewey SL, Smith GS, Logan J, Brodie JD, Yu DW, Ferrieri RA, King PT, MacGregor RR, Martin TP, Wolf AP, Volkow ND, Fowler JS, Meller E. 1992. GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography. J Neurosci 12:3773-3780.
17. Dewey SL, Morgan AE, Ashby CR Jr, Horan B, Kushner SA, Logan J, Volkow ND, Fowler JS, Gardner EL, Brodie JD. 1998. A novel strategy for the treatment of cocaine addiction. Synapse 30:119-129.
18. Dewey SL, Brodie JD, Gerasimov M, Horan B, Gardner EL, Ashby CR Jr. 1999. A pharmacologic strategy for the treatment of nicotine addiction. Synapse 31:76-86.
19. Di Chiara G, Imperato A. 1988. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278.
20. Epstein DH, Preston KL. 2003. The reinstatement model and relapse prevention: A clinical perspective. Psychopharmacology 168:31-41.
21. Fechtner RD, Khouri AS, Figueroa E, Ramirez M, Federico M, Dewey SL, Brodie JD. 2006. Short-term treatment of cocaine and / or methamphetamine abuse with vigabatrin: Ocular safety pilot results. Arch Ophthalmol 124:1257-1262.
22. Funada M, Sato M, Makino Y, Wada K. 2002. Evaluation of rewarding effect of toluene by the conditioned place preference procedure in mice. Brain Res Protoc 10:47-54.
23. Gardner EL, Schiffer WK, Horan BA, Highfield D, Dewey SL, Brodie JD, Ashby CR Jr. 2002. γ-Vinyl GABA, an irreversible inhibitor of GABA transaminase, alters the acquisition and expression of cocaine-induced sensitization in male rats. Synapse 46:240-250.
24. Gatley SJ, Meehan SM, Chen R, Pan D-F, Schechter MD, Dewey
25. SL. 1996. Place preference and microdialysis studies with two derivatives of methylphenidate. Life Sci 58:345-352.
26. Gerasimov MR, Dewey SL. 1999. γ-Vinyl γ-aminobutyric acid attenuates the synergistic elevations of nucleus accumbens dopamine produced by a cocaine/heroin (speedball) challenge. Eur J Pharmacol 380:1-4.
27. Gerasimov MR, Dewey SL. 2003. Development of a GABAergic treatment for substance abuse using PET. Drug Dev Res 59:240-248.
28. Gerasimov MR, Ashby CR Jr, Gardner EL, Mills MJ, Brodie JD, Dewey SL. 1999. γ-Vinyl GABA inhibits methamphetamine, heroin, or ethanolinduced increases in nucleus accumbens dopamine. Synapse 34:11-19.
29. Gerasimov MR, Schiffer WK, Gardner EL, Marsteller DA, Lennon IC, Taylor SJC, Brodie JD, Ashby CR Jr, Dewey SL. 2001. GABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamine. Eur J Pharmacol 414:205-209.
30. Hiranita T, Anggadiredja K, Fujisaki C, Watanabe S, Yamamoto T. 2004. Nicotine attenuates relapse to methamphetamine-seeking behavior (craving) in rats. Ann N Y Acad Sci 1025:504-507.
31. Hiroi N, White NM. 1991. The amphetamine conditioned place preference: Differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas. Brain Res 552:141-152.
32. Itzhak Y, Martin JL. 2002. Cocaine-induced conditioned place preference in mice: Induction, extinction and reinstatement by related psychostimulants. Neuropsychopharmacology 26:130-134.
33. Jung MJ, Lippert B, Metcalf BW, Bohlen P, Schechter PJ. 1977. γ-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: Effects on brain GABA metabolism in mice. J Neurochem 29:797-802.
34. Katz JL, Higgins ST. 2003. The validity of the reinstatement model of craving and relapse to drug use. Psychopharmacology 168:21-30.
35. Kushner SA, Dewey SL, Kornetsky C. 1997. γ-Vinyl GABA attenuates cocaine-induced lowering of brain stimulation reward thresholds. Psychopharmacology 133:383-388.
36. Kushner SA, Dewey SL, Kornetsky C. 1999. The irreversible γ-aminobutyric acid (GABA) transaminase inhibitor γ-vinyl-GABA blocks cocaine self-administration in rats. J Pharmacol Exp Ther 290:797-802.
37. Lê AD, Quan B, Juzytch W, Fletcher PJ, Joharchi N, Shaham Y. 1998. Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats. Psychopharmacology 135:169-174.
38. Lee DE, Schiffer WK, Dewey SL. 2004. γ-Vinyl GABA (Vigabatrin) blocks the expression of toluene-induced conditioned place preference (CPP). Synapse 54:183-185. Li SM, Ren YH, Zheng JW. 2002. Effect of 7-nitroindazole on drug-priming reinstatement of D-methamphetamine-induced conditioned place preference. Eur J Pharmacol 443:205-206.
39. Manzanedo C, Aguilar MA, Rodriguez-Arias M, Minarro J. 2001. Conditioned place preference paradigm can be a mouse model of relapse to opiates. Neurosci Res Commun 28:23-29.
40. Mazurkiewicz M, Sirviö J, Riekkinen P Sr. 1993. Effects of single and repeated administration of vigabatrin on the performance of non-epileptic rats in a delayed non-matching to position task. Epilepsy Res 15:221-227.
41. McFarland K, Ettenberg A. 1997. Reinstatement of drug-seeking behavior produced by heroin-predictive environmental stimuli. Psychopharmacology 131:86-92.
42. Moffett MC, Goeders NE. 2007. CP-154,526, a CRF type-1 receptor antagonist, attenuates the cue-and methamphetamine-induced reinstatement of extinguished methamphetamine-seeking behavior in rats. Psychopharmacology 190:171-180.
43. Molina PE, Ahmed N, Ajmal M, Dewey S, Volkow N, Fowler J, Abumrad N. 1999. Co-administration of γ-vinyl GABA and cocaine: Preclinical assessment of safety. Life Sci 65:1175-1182.
44. Morgan AE, Dewey SL. 1998. Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine. Synapse 28:60-65.
45. Mucha RF, Van Der Kooy D, O'Shaughnessy M, Bucenieks P. 1982. Drug reinforcement studied by the use of place conditioning in rat. Brain Res 243:91-105.
46. Mueller D, Stewart J. 2000. Cocaine-induced conditioned place preference: Reinstatement by priming injections of cocaine after extinction. Behav Brain Res 115:39-47.
47. O'Brien CP, Gardner EL. 2005. Critical assessment of how to study addiction and its treatment: Human and non-human animal models. Pharmacol Ther 108:18-58.
48. O'Dea PJ, Murphy B, Balzer C. 1997. Traffic and illegal production of drugs in rural America. NIDA Res Monogr 168:79-89.
49. Parker LA, McDonald RV. 2000. Reinstatement of both a conditioned place preference and a conditioned place aversion with drug primes. Pharmacol Biochem Behav 66:559-561.
50. Paterson NE, Markou A. 2002. Increased GABA neurotransmission via administration of γ-vinyl GABA decreased nicotine self-administration in the rat. Synapse 44:252-253.
51. Paul M, Dewey SL, Gardner EL, Brodie JD, Ashby CR Jr. 2001. γ-Vinyl GABA (GVG) blocks expression of the conditioned place preference response to heroin in rats. Synapse 41:219-220.
52. Peng XQ, Li X, Gilbert JG, Pak AC, Ashby CR Jr, Brodie JD, Dewey SL, Gardner EL, Xi ZX. 2007. γ-Vinyl GABA inhibits cocaine- trigered reinstatement of drug-seeking behavior in rats by a non-do- paminergic mechanism. Drug Alcohol Depend (in press).
53. Popik P, Wrobel M, Bisaga A. 2006. Reinstatement of morphine-conditioned reward is blocked by memantine. Neuropsychopharmacology 31:160-170.
54. Rawson RA, Condon TP. 2007. Why do we need an addiction supplement focused on methamphetamine? Addiction 102:1-4.
55. Robinson TE, Berridge KC. 1993. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res Rev 18:247-291.
56. Roma PG, Riley AL. 2005. Apparatus bias and the use of light and texture in place conditioning. Pharmacol Biochem Behav 82:163-169.
57. Schiffer WK, Gerasimov M, Hofmann L, Marsteller D, Ashby CR, Brodie JD, Alexoff DL, Dewey SL. 2001. γ Vinyl-GABA differentially modulates NMDA antagonist-induced increases in mesocortical versus mesolimbic DA transmission. Neuropsychopharmacology 25:704-712.
58. Self DW, Nestler EJ. 1998. Relapse to drug-seeking: Neural and molecular mechanisms. Drug Alcohol Depend 51:49-60.
59. Shaham Y, Shalev U, Lu L, de Wit H, Stewart J. 2003. The reinstatement model of drug relapse: History, methodology and major findings. Psychopharmacology 168:3-20.
60. Slusher BS, Thomas A, Paul M, Schad CA, Ashby CR Jr. 2001. Expression and acquisition of the conditioned place preference response to cocaine in rats is blocked by selective inhibitors of the enzyme N-acetylated-α-linked-acidic dipeptidase (NAALADase). Synapse 41:22-28.
61. Sora I, Wichems C, Takahashi N, Li XF, Zeng Z, Revay R, Lesch KP, Murphy DL, Uhl GR. 1998. Cocaine reward models: Conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci USA 95:7699-7704.
62. Stewart J, de Wit H, Eikelboom R. 1984. Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol Rev 91:251-268.
63. Stromberg MF, Mackler SA, Volpicelli JR, O'Brien CP, Dewey SL. 2001. The effect of γ-vinyl-GABA on the consumption of concurrently available oral cocaine and ethanol in the rat. Pharmacol Biochem Behav 68:291-299.
64. Tahsili-Fahadan P, Yahyavi-Firouz-Abadi N, Khoshnoodi MA, Motiei-Langroudi R, Tahaei SA, Ghahremani MH, Dehpour AR. 2006. Agmatine potentiates morphine-induced conditioned place preference in mice: Modulation by α2-adrenoceptors. Neuropsy-chopharmacology 31:1722-1732.
65. Takada K, Yanagita T. 1997. Drug dependence study on vigabatrin in rhesus monkeys and rats. Arzneimittelforschung 47:1087-1092.
66. Tzschentke TM. 2007. Measuring reward with the conditioned place preference (CPP) paradigm: Update of the last decade. Addict Biol 12:227-462.
67. U.S. National Institutes of Health. 2000. ClinicalTrials.gov: A service of the U.S. National Institutes of Health. Available at http://www. clinicaltrials.gov., Identifier NCT00527683.
68. Wang B, Luo F, Zhang WT, Han JS. 2000. Stress or drug priming induces reinstatement of extinguished conditioned place preference. Neuroreport 11:2781-2784.
69. Woolverton WL, Cervo L, Johanson CE. 1984. Effects of repeated methamphetamine administration on methamphetamine self-administration in rhesus monkeys. Pharmacol Biochem Behav 21:737-741.
70. Xi J, Kruzich PJ. 2007. Black agouti (ACI) rats show greater drug- and cue-induced reinstatement of methamphetamine-seeking behavior than Fischer 344 and Lewis rats. Pharmacol Biochem Behav 87:90-97.
71. Xi ZX, Stein EA. 2000. Increased mesolimbic GABA concentration blocks heroin self-administration in the rat. J Pharmacol Exp Ther 294:613-619.
72. Yan Y, Nitta A, Mizoguchi H, Yamada K, Nabeshima T. 2006. Relapse of methamphetamine-seeking behavior in C57BL/6J mice demonstrated by a reinstatement procedure involving intravenous self-administration. Behav Brain Res 168:137-143.
73. Yan Y, Yamada K, Nitta A, Nabeshima T. 2007. Transient drug-primed but persistent cue-induced reinstatement of extinguished methamphetamine-seeking behavior in mice. Behav Brain Res 177:261-268.